Impel NeuroPharma

Rain Therapeutics headlines newest slate of IPO-bound biotechs with $100M penciled in for lead oncology program
Endpoints
Mon, 04/5/21 - 10:21 pm
IPOs
Rain Therapeutics
Impel NeuroPharma
Anebulo Pharmaceuticals
Seattle’s Impel NeuroPharma bags $67.5M crossover raise for a round of new drug/device CNS clinical trials
Endpoints
Fri, 12/7/18 - 12:08 pm
Impel NeuroPharma
drug delivery
drug-device combos
devices
Impel NeuroPharma readies trial for intranasal drug-device migraine treatment
Drug Delivery Business News
Fri, 06/22/18 - 07:50 pm
Impel NeuroPharma
FDA
INP104
migraines
intra-nasal drug delivery